Litcius/Paper detail

LBO-001 Norucholic acid for the treatment of primary sclerosing cholangitis: 96-week analysis of a pivotal phase 3 trial

Michael Trauner, Palak Trivedi, Gerald Denk, Martti Färkkilâ, Peter Schirmacher, Stefan G. Hübscher, Michael T. Dill, Gerda Elisabeth Villadsen, Christoph P. Berg, Kristin Kaasen Jørgensen, Marcel Vetter, Münevver Demir, Andreas E. Kremer, Christoph Schramm, Christian P. Strassburg, Heike Bantel, Tobias Böttler, Ulrich Beuers, Alexandre Louvet, Emina Halilbasic, Michael Stieß, Markus Proels, R. Müller, Peter Fickert, Michael P. Manns

2025Journal of Hepatology11 citationsDOI

Topics & Concepts

Primary sclerosing cholangitisMedicineGastroenterologyInternal medicinePrimary (astronomy)Phase (matter)ChemistryDiseasePhysicsOrganic chemistryAstronomyLiver Diseases and ImmunityLiver Disease Diagnosis and TreatmentLiver Disease and Transplantation
LBO-001 Norucholic acid for the treatment of primary sclerosing cholangitis: 96-week analysis of a pivotal phase 3 trial | Litcius